Journal article 4 views
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
Darren K. McGuire,
Nikolaus Marx,
Sharon L. Mulvagh,
John E. Deanfield,
Silvio E. Inzucchi,
Rodica Pop-Busui,
Johannes F.E. Mann,
Scott S. Emerson,
Neil R. Poulter,
Mads D.M. Engelmann,
Maria Sejersten Ripa,
G. Kees Hovingh,
Kirstine Brown-Frandsen,
Steve Bain 
,
Matthew A. Cavender ,
Mette Gislum,
Jens-Peter David,
John B. Buse
,
Matthew A. Cavender ,
Mette Gislum,
Jens-Peter David,
John B. Buse
New England Journal of Medicine, Volume: 392, Issue: 20, Pages: 2001 - 2012
Swansea University Author:
Steve Bain
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1056/nejmoa2501006
Abstract
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
| Published in: | New England Journal of Medicine |
|---|---|
| ISSN: | 0028-4793 1533-4406 |
| Published: |
Massachusetts Medical Society
2025
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa69194 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
20 |
| Start Page: |
2001 |
| End Page: |
2012 |